Frede Olesen. Frede Olesen
|
|
|
- Lorraine Beasley
- 10 years ago
- Views:
Transcription
1 Professor, DrMedSc, GP, FRCGP(hon.) The Research Unit for General Practice, Aarhus University Chairman of the board of The Danish Cancer Society
2 The pathway to better results Support to realtives Terminal care Palliation Follow up, recurrence Treatment Rehabilitation Confirmed detailed diagnosis Primary diagnostic procedures, waits, available service Symptoms which symptoms predictive value Crisis Perceived symptoms, treshold for contact to Gen. Practice Screene Need for GP Lifestyle, health promotion, prevention
3 The disease journey Today s focus Palliation Support to realtives Terminal care Follow up, recurrence Treatment Rehabilitation Confirmed detailed diagnosis Primary diagnostic procedures, waits, available service Symptoms which symptoms predictive value Crisis Perceived symptoms, treshold for contact to Gen. Practice Screene Need for GP Lifestyle, health promotion, prevention
4 Waits are unacceptable: Cancer as an acute disease the 3-point strategy from the Danish Cancer Society in : Improved acces to relevant diagnostic investigations without waits when required by the front line care in a heath care system (general practice) Reduce double gatekeeping 2: Diagnostic centres at all major hospitals Multidisciplinary acute assessment by specialists without waits A patient can be referred with the diagnosis: I suspect serious disease, but I do not know which disease cancer is a possibility 3: Fast track clinical pathways when a specific cancer is considered The fast track packages have been developed by multidisciplinary cancer groups in a process led by the National Board of Health Regional multidisciplinary cancer groups implement the strategy FROM 2007 MASSIVE POLITICAL AND MANAGEMENT FOCUS ON CANCER AS AN ACUTE DISEASE
5 Waits are unacceptable: Cancer as an acute disease the 3-point strategy from the Danish Cancer Society in : Improved acces to relevant diagnostic investigations without waits when required by the front line care in a heath care system (general practice) Reduce double gatekeeping 2: Diagnostic centres at all major hospitals Multidisciplinary acute assessment by specialists without waits A patient can be referred with the diagnosis: I suspect serious disease, but I do not know which disease cancer is a possibility 3: Fast track clinical pathways when a specific cancer is considered The fast track packages have been developed by multidisciplinary cancer groups in a process led by the National Board of Health Regional multidisciplinary cancer groups implement the strategy
6 Waits are unacceptable: Cancer as an acute disease the 3-point strategy from the Danish Cancer Society in : Improved acces to relevant diagnostic investigations without waits when required by the front line care in a heath care system (general practice) Reduce double gatekeeping 2: Diagnostic centres at all major hospitals Multidisciplinary acute assessment by specialists without waits A patient can be referred with the diagnosis: I suspect serious disease, but I do not know which disease cancer is a possibility 3: Fast track clinical pathways when a specific cancer is considered The fast track packages have been developed by multidisciplinary cancer groups in a process led by the National Board of Health Regional multidisciplinary cancer groups implement the strategy
7 Worldwide: we all appreciate the good sides of fast track pathway packages for serious disease But: it is dangerous as the only approach to first line diagnostics! The problem: can only be used, when cancer is very likely
8 Why did the Danish Cancer Society demand the 3-step strategy
9 Diagnostic scan Progression in tumor-size, but stage unchanged (T4) Treatment planning scan A patient with 19 days between scans. Note the bone destruction AR Jensen et al. Radiother Oncol 2007
10 Diagnostic scan Progression in N-site, but stage unchanged (N3) Treatment planning scan A patient with 47 days in between scans. Note growth of the lymph node metastasis and appearance of a contralaterale metastasis AR Jensen et al. Radiother Oncol 2007
11 Time intervals and milestones in early diagnosis Diagnostic delay Weller, Vedsted, Rubin G, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106: doi: /bjc
12 System-related delay before or whether the system reacts appropriately? Delay in days % percentile: 32 days Median: 55 days 75% percentile: 93 days Patients Delay > 1 year = 365 days Rikke Pilegaard Hansen. PhD. 2008; Aarhus University
13 When do we classify cancer stage? Danish patients are diagnosed in a later stage One of the most frequent statements made, but we do not know if it is true If you make health care planning based on this assumption you may make great mistakes The blind spot is the length of the clinical pathway Danish patients are in a later stage, when treatment starts!!! This may be due to late presentation, late suspicion of cancer and a slow clinical pathway within the health care system To which extent does a slow clinical pathway influence prognosis?
14 The missing link in the diagnosis of serious disease What do we know about the journey from first symptom to start of the specific tratment? Can we improve and shorten the diagnostic proces? A major hitherto neglected research focus The Danish Cancer Society and the Novo Nordic Foundation have initiated and funded this reseach including the Research Centre for early diagnosis of cancer i Aarhus the CaP centre led by Prof. Peter Vedsted Silkeborg and Vejle Hospitals led the development of new thinking about organisation of the diagnostic process within the hospital A special focus on service in the first line diagnostic process
15 Positive predictive value of alarm symtoms in GP - a GP must investigate or refer between 13 and 50 patients to find one cancer in patients with alarm symptoms Blood in the urine Difficulty in swallowing Blood in sputum Men Women N Cancer PPV 3 year Cancer PPV 3year ,4% 162 3,4% ,7% 81 2,4% ,5% 81 4,3% Blood in stools ,4% 154 2,0% Jones R et al. BMJ 2007;334;1040
16 Total delay (mean) Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec
17 Total delay (mean) Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec
18 E.g. Presenting symptoms in 1900 consecutive newly diagnosed cancer patients Nielsen, Hansen, Vedsted. Ugeskr Læger. 2010;172:
19 Total delay (mean) Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec
20 Total delay (mean) Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec
21 Total delay (mean) Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec
22 Total delay (mean) Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec
23 A wrong way of analysing data Dødsrisiko efter 3år Ventetid uger
24 A slow diagnostic process influences prognosis - a UK estimate: lives/year -in Denmark with 5.5 mill. inhab.: /year
25 The 3-step model for improvement If it is simple : Access to quick and correct diagnostic tests If it is difficult: Access to comprehensive diagnostic service If we think we know: The fast track package, when we know the way forward
26 Let us share our experiences and learn more
27 Total delay (mean) Patient, Fordeling doctor af and patient, system læge delay og system in a cohort delay - Only 50% present with obvious signs of cancer The focus for this conference Alarm 49,7% 49.7% Almen 23.9% Ukarakteristisk 26.4% Lægens svar vedr. symptomtolkning General 23,9 % Non char. symptoms 26,4% Patientdelay Systemdelay Prim Doctor Lægedelay PHC Systemdelay Sec
28 The cancer journey Todays focus Palliation Support to realtives Terminal care Follow up, recurrence Treatment Rehabilitation Confirmed detailed diagnosis Primary diagnostic procedures, waits, available service Symptoms which symptoms predictive value Crisis Perceived symptoms, treshold for contact to Gen. Practice Screene Need for GP Lifestyle, health promotion, prevention
29 The hospital as service provider to general practice in a comprehensive seamless health care system
30 The ultimate aim: a better general approach to appropriate and quick diagnosis in a health care system. A large locomotive for general improvements in early diagnosis of serious disease
Torben Palshof, MD, DMSci Dept. of Oncology, Aarhus University Hospital
Introduction Torben Palshof, MD, DMSci Dept. of Oncology, Aarhus University Hospital Chairman: Danish Lung Cancer Group (DLCG) & The Cooperative of Danish Multidisciplinary Cancer Groups in Denmark Managerial
There are many different types of cancer and sometimes cancer is diagnosed when in fact you are not suffering from the disease at all.
About Cancer Cancer is a disease where there is a disturbance in the normal pattern of cell replacement. The cells mutate and become abnormal or grow uncontrollably. Not all tumours are cancerous (i.e.
Follow-up care plan after treatment for breast cancer. A guide for General Practitioners
Follow-up care plan after treatment for breast cancer A guide for General Practitioners This leaflet provides information for GPs on the follow-up care required by women who had breast cancer. It is for
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group
Komorbide brystkræftpatienter kan de tåle behandling? Et registerstudie baseret på Danish Breast Cancer Cooperative Group Lotte Holm Land MD, ph.d. Onkologisk Afd. R. OUH Kræft og komorbiditet - alle skal
Guideline for the Follow Up of Patients Following Treatment for Breast Cancer
Guideline for the Follow Up of Patients Following Treatment for Breast Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Page 1 of 6 1 Scope of the Guideline This guideline
Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data
The 2014 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2013 More than 70 percent of all newly diagnosed cancer patients are treated in the more than 1,500
The new Heart Failure pathway
The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising
Am I likely to develop. rheumatoid Arthritis? A guide for people with joint symptoms
Am I likely to develop Rheumatoid rheumatoid Arthritis? arthritis? A guide for people with joint symptoms At a glance Rheumatoid arthritis (RA) is a common disease that causes painful and swollen joints,
OBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
AA Life Insurance providing access to Best Doctors. AA Life Insurance is provided by Friends Life and Pensions Limited
AA Life Insurance is provided by Friends Life and Pensions Limited What would be the first thing you might think about if you were diagnosed with a serious illness? 2 It is very likely that the first thing
Appendix D- Monoclonal Gammopathy of Undetermined Significance (MGUS)
Local Enhanced Service: Primary care management of stable haematological patients Monoclonal Gammopathy of Undetermined Significance (MGUS) 1. Introduction Monoclonal Gammopathy of Undetermined Significance
Treating Mesothelioma - A Quick Guide
Treating Mesothelioma - A Quick Guide Contents This is a brief summary of the information on Treating mesothelioma from CancerHelp UK. You will find more detailed information on the website. In this information
Breast Cancer. Presentation by Dr Mafunga
Breast Cancer Presentation by Dr Mafunga Breast cancer in the UK Breast cancer is the second most common cancer in women. Around 1 in 9 women will develop breast cancer It most commonly affects women over
Lung Cancer. This reference summary will help you better understand lung cancer and the treatment options that are available.
Lung Cancer Introduction Lung cancer is the number one cancer killer of men and women. Over 165,000 people die of lung cancer every year in the United States. Most cases of lung cancer are related to cigarette
The recommendations made throughout this book are by the National Health and Medical Research Council (NHMRC).
INTRODUCTION This book has been prepared for people with bowel cancer, their families and friends. The first section is for people with bowel cancer, and is intended to help you understand what bowel cancer
Nurse Practitioner Role Primary Health Care In General Practice Setting.
Nurse Practitioner Role Primary Health Care In General Practice Setting. The role of a nurse practitioner is to provide autonomous patient consultations. It also involves working in collaboration with
OVARIAN CANCER TREATMENT
OVARIAN CANCER TREATMENT Cancer Care Pathways Directorate Tailored Information in Cancer Care (TICC) Sir Anthony Mamo Oncology Centre National Cancer Plan May 2015 Contents About this booklet 1 The Ovaries
Knowledge develops nursing care to the benefit of patients, citizens, professionals and community
Knowledge develops nursing care to the benefit of patients, citizens, professionals and community Danish Nurses Organization Research Strategy 2011 Danish Nurses Organization Front page: Elephant Landscape
Screening for Prostate Cancer
Cancer Expert Working Group on Cancer Prevention and Screening Screening for Prostate Cancer Information for men and their families 1 What is the prostate? 2 What is prostate cancer? prostate The prostate
What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide
What If I Have a Spot on My Lung? Do I Have Cancer? Patient Education Guide A M E R I C A N C O L L E G E O F C H E S T P H Y S I C I A N S Lung cancer is one of the most common cancers. About 170,000
Module I October 18-22, 2015 JW Marriott Marquis Hotel, Dubai, UAE
CME Accreditation is under process Module 1: Diabetes Facts and Diabetes in the Clinic Module 2: Nursing theory and educational (pedagogical) tools to advise and educate people with diabetes and their
Xerox Custom Healthcare Solution
Xerox Custom Healthcare Solution Xerox HR Services has undertaken a comprehensive review of the employee benefits market, assessing all of the major providers, in order to develop our Xerox Custom Healthcare
Questions to Ask My Doctor About Breast Cancer
Questions to Ask My Doctor Being told you have breast cancer can be scary and stressful. You probably have a lot of questions and concerns. Learning about the disease, how it s treated, and how this information
bowel cancer screening
bowel cancer screening take control of your health www.bupacromwellhospital.com Bowel cancer is the third most common cancer in both men and women in the UK. The condition is treatable if diagnosed in
Chapter 15 Multiple myeloma
Chapter 15 Multiple myeloma Peter Adamson Summary In the UK and in the 199s, multiple myeloma accounted for around 1 in 8 diagnosed cases of cancer and 1 in 7 deaths from cancer. There was relatively little
National Clinical Programmes
National Clinical Programmes Section 3 Background information on the National Clinical Programmes Mission, Vision and Objectives July 2011 V0. 6_ 4 th July, 2011 1 National Clinical Programmes: Mission
The Center for Prostate Cancer. Personalized Treatment. Clinical Excellence.
The Center for Prostate Cancer Personalized Treatment. Clinical Excellence. The Center for Prostate Cancer Leaders in Prostate Cancer Treatment and Research The Center for Prostate Cancer at the North
Diabetes Management in the Primary Care Setting
APNA Online Learning www.apna.asn.au/onlinelearning Diabetes Management in the Primary Care Setting Course Summary Diabetes Management in the Primary Care Setting is an online learning program aimed at
Neuromuscular disorders Development of consensus for diagnosis and standards of care. Thomas Sejersen, Pediatric neurology
Neuromuscular disorders Development of consensus for diagnosis and standards of care Thomas Sejersen, Pediatric neurology What are neuromuscular disorders? How does the field of neuromuscular disorders
AA Life Insurance providing access to Best Doctors. AA Life Insurance is provided by Friends Life Limited
AA Life Insurance is provided by Friends Life Limited What would be the first thing you might think about if you were diagnosed with a serious illness? It is very likely that the first thing you might
Lung Cancer Multidisciplinary Meeting Toolkit. National Lung Cancer Working Group
Lung Cancer Multidisciplinary Meeting Toolkit National Lung Cancer Working Group September 2014 Contents Introduction 1 Multidisciplinary meetings 1 Toolkit for implementing high-quality lung cancer MDMs
Us TOO University Presents: Understanding Diagnostic Testing
Us TOO University Presents: Understanding Diagnostic Testing for Prostate Cancer Patients Today s speaker is Manish Bhandari, MD Program moderator is Pam Barrett, Us TOO International Made possible by
Ch. 14 - Medical Coding and Claims. A bill sent to the insurance carrier for payment related to patient care
A bill sent to the insurance carrier for payment related to patient care A claim held or rejected by the insurance carrier due to problems or errors A coding system published by the US department of Health
Data Mining On Diabetics
Data Mining On Diabetics Janani Sankari.M 1,Saravana priya.m 2 Assistant Professor 1,2 Department of Information Technology 1,Computer Engineering 2 Jeppiaar Engineering College,Chennai 1, D.Y.Patil College
Cancer research in the Midland Region the prostate and bowel cancer projects
Cancer research in the Midland Region the prostate and bowel cancer projects Ross Lawrenson Waikato Clinical School University of Auckland MoH/HRC Cancer Research agenda Lung cancer Palliative care Prostate
Mobile Telecommunications in Kempten West Blood levels alarmingly altered
Mobile Telecommunications in Kempten West Blood levels alarmingly altered The Citizens Initiative Kempten West, which was established after the installation of the T-Mobile transmitter on the bank building
The End of Life Care Strategy promoting high quality care for all adults at the end of life. Prof Mike Richards July 2008
The End of Life Care Strategy promoting high quality care for all adults at the end of life Prof Mike Richards July 2008 The End of Life Care Strategy: Rationale (1) Around 500,000 people die in England
Childhood cancer in primary care from symptom to treatment. PhD dissertation. Jette Møller Ahrensberg
Childhood cancer in primary care from symptom to treatment PhD dissertation Jette Møller Ahrensberg Health Aarhus University 2012 Childhood cancer in primary care from symptom to treatment PhD student:
Medicolegal -as expert, not defendant!!
Medicolegal -as expert, not defendant!! Professor Pat Price Ralston Paterson Professor of Radiation Oncology, Christie Hospital, University of Manchester Management in Radiology RSM [email protected] 22-23
Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for 2002-2006
Multiple Myeloma Figure 16 Definition: Multiple myeloma forms in plasma cells that are normally found in the bone marrow. 1 The plasma cells grow out of control and form tumors (plasmacytoma) or crowd
Mads Lind Ingeman 1,2,3*, Morten Bondo Christensen 1, Flemming Bro 1, Søren T. Knudsen 4 and Peter Vedsted 1,2
Ingeman et al. BMC Cancer (2015) 15:421 DOI 10.1186/s12885-015-1424-5 RESEARCH ARTICLE The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer a cross-sectional study
Inflammatory breast cancer
april 2007 information about Inflammatory breast cancer What is inflammatory breast cancer? Inflammatory breast cancer is a rare and rapidly growing form of breast cancer. Unlike other breast cancers which
How To Prepare A Meeting For A Health Care Conference
THORACIC ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY EXECUTIVE SUMMARY 1. All patients in Lothian with thoracic malignancies should be discussed at designated times in pathway (see App
The TV Series. www.healthybodyhealthymind.com INFORMATION TELEVISION NETWORK
The TV Series www.healthybodyhealthymind.com Produced By: INFORMATION TELEVISION NETWORK ONE PARK PLACE 621 NW 53RD ST BOCA RATON, FL 33428 1-800-INFO-ITV www.itvisus.com 2005 Information Television Network.
Salisbury Lung Cancer Service (1 of 5)
Salisbury Lung Cancer Service (1 of 5) i If you need this information in another language or medium (audio, large print, etc) please contact Customer Care on 0800 374 208 email: customercare@ salisbury.nhs.uk.
Guide to Claims against General Practitioners (GPs)
Patients often build up a relationship of trust with their GP over a number of years. It can be devastating when a GP fails in his or her duty to a patient. Our medical negligence solicitors understand
This vision does not represent government policy but provides useful insight into how breast cancer services might develop over the next 5 years
Breast Cancer 2015 Annex C Background 1. Breast cancer is the most common cancer in women in England with (not including cases of ductal carcinoma in situ (DCIS) 1 ) 39,681 new cases diagnosed in 2008
Ovarian cancer. Patient information from the BMJ Group. What is ovarian cancer? What are the symptoms?
Patient information from the BMJ Group Ovarian cancer Ovarian cancer is a serious disease. If it s diagnosed at an early stage, ovarian cancer can usually be cured. But even cancers that are more advanced
PRIMARY LUNG CANCER TREATMENT
PRIMARY LUNG CANCER TREATMENT Cancer Care Pathways Directorate Tailored Information in Cancer Care (TICC) Sir Anthony Mamo Oncology Centre December 2014 Contents About this booklet 1 Types of Lung Cancer
What is hospice care? Answering questions about hospice care
What is hospice care? Answering questions about hospice care Introduction If you, or someone close to you, have a life-limiting or terminal illness, you may have questions about the care you can get and
2.1 Who first described NMO?
History & Discovery 54 2 History & Discovery 2.1 Who first described NMO? 2.2 What is the difference between NMO and Multiple Sclerosis? 2.3 How common is NMO? 2.4 Who is affected by NMO? 2.1 Who first
UICC World Cancer Congress. Cancer Staging and Quality of Care
UICC World Cancer Congress August 27 30, 2012, Montreal CANCER STAGE: A neglected cornerstone of Cancer Control Cancer Staging and Quality of Care Christian Wittekind Institut für Pathologie UKL 1 Agenda!
Prostate cancer A guide for newly diagnosed men
Prostate cancer A guide for newly diagnosed men 2 Prostate cancer A guide for newly diagnosed men About this booklet This booklet is for men who have recently been diagnosed with prostate cancer. It is
Platinum Healthcare Plan Benefit comparison of Bronze, Silver, Gold & Platinum healthcare plans
Platinum Healthcare Plan Benefit comparison of Bronze, Silver, Gold & Platinum healthcare plans Benefit description Maximum benefit Area of Cover ) Within stated benefit limits - 6 week wait rule applies
The Effectiveness of an Outpatient Interdisciplinary Team in Reducing Distress with Lung Cancer Patients
The Effectiveness of an Outpatient Interdisciplinary Team in Reducing Distress with Lung Cancer Patients Shirley Witko Senior Social Worker Sir Charles Gairdner Hospital, Perth Delivering a Healthy WA
Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics
Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics Response by the Genetic Interest Group Question 1: Health
U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet
U.K. Familial Ovarian Cancer Screening Study (UK FOCSS) Phase 2 Patient Information Sheet 1. Invitation You are being invited to take part in a research study. Before you decide it is important for you
Why Service Users Say They Value Specialist Palliative Care Social Work:
Why Service Users Say They Value Specialist Palliative Care Social Work: and how the medicalisation of palliative care gets in the way Suzy Croft and Peter Beresford Palliative Care Palliative Care is
How do I find the best place to get treatment for my lymphoma?
Produced November 2010 Next revision due November 2012 How do I find the best place to get treatment for my lymphoma? Introduction Fortunately this is not a question that patients with cancers of the blood
Kidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
PRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE
PRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE MARCH 2013 MONOGRAPHS IN PROSTATE CANCER OUR VISION, MISSION AND VALUES Prostate Cancer Foundation of Australia (PCFA)
a health technology assessment Summary Danish Health Technology Assessment funded projects 2010;10(3)
Rehabilitation after breast cancer, colorectal cancer and prostate cancer a health technology assessment Summary 2010 Danish Health Technology Assessment funded projects 2010;10(3) Rehabilitation after
Invasive lobular breast cancer
Invasive lobular breast cancer This booklet is about invasive lobular breast cancer. It describes what invasive lobular breast cancer is, the symptoms, how it s diagnosed and possible treatments. Diagnosed
Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC)
Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC) FDA Presentation ODAC Meeting September 14, 2011 1 Review Team Paul G. Kluetz,
Prostate Cancer Screening
Prostate Cancer Screening The American Cancer Society and Congregational Health Ministry Team June Module To access this module via the Web, visit www.cancer.org and type in congregational health ministry
Advanced prostate cancer
1 Advanced prostate cancer In this fact sheet: What is advanced (metastatic) prostate cancer? What tests are used to diagnose advanced prostate cancer? What do my test results mean? What are my treatment
Cutaneous Lymphoma FAST FACTS
Cutaneous Lymphoma FAST FACTS What is Cutaneous Lymphoma? Cutaneous lymphomas are types of non-hodgkin s lymphomas (NHL) that originate in the lymphocytes (white blood cells). Unlike most other types of
Smoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?
Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or
PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER?
PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER? PCA3 DETECTION TEST FOR PROSTATE CANCER There is a range of methods available to your healthcare professional to verify the
1. Requirements for early detection, diagnosis and treatment. Preliminary considerations
EUROPEAN GUIDELINES FOR CANCER PATIENTS RIGHTS Edited by the ECL s European network on patients' and health professionals rights and duties Athens, 16 th October 2004 Preliminary considerations A diagnosis
Tubular breast cancer
Tubular breast cancer This booklet is for people who would like more information about tubular breast cancer. It describes what tubular breast cancer is, its symptoms, how a diagnosis is made and the possible
It can be devastating to be diagnosed with a cancer like multiple myeloma. But there are treatments that can help you live longer and feel better.
Patient information from the BMJ Group It can be devastating to be diagnosed with a cancer like multiple myeloma. But there are treatments that can help you live longer and feel better. What is multiple
Guidelines for Management of Renal Cancer
Guidelines for Management of Renal Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Versions 2 and 3 Section 5 updated bullets 5.3 and 5.4 Section 6 updated
How To Manage A Cancer Oncology Clinic
GYNAECOLOGICAL ONCOLOGY MULTIDISCIPLINARY TEAM MEETINGS: OPERATIONAL POLICY Version 3 Policy agreed Sept 2009 (updated Jan/Feb 2013) Agreed by: SCAN gynae group 2009 Update agreed SCAN gynae group May
SSNAP s Acute Organisational Audit Report 2012: Performance Summary for South London
SSNAP s Acute Organisational Audit Report 2012: Performance Summary for South London The Sentinel Stroke National Audit Programme (SSNAP) s Acute Organisational Audit looks at how stroke services across
Investigation into the death of Mr George Joseph, a prisoner at HMP Belmarsh, in April 2015
Investigation into the death of Mr George Joseph, a prisoner at HMP Belmarsh, in April 2015 Crown copyright 2015 This publication is licensed under the terms of the Open Government Licence v3.0 except
Early Prostate Cancer: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
Community health care services Alternatives to acute admission & Facilitated discharge options. Directory
Community health care services Alternatives to acute admission & Facilitated discharge options Directory Introduction The purpose of this directory is to provide primary and secondary health and social
